Evidence map›Paper›PMID 36631689›Full record

ArticleEuropean journal of pediatrics2023

CD38

Maria Vincenza Mastrolia, Silvia Boscia, Luisa Galli, Lorenzo Lodi, Laura Pisano, Ilaria Maccora, Silvia Ricci, Ilaria Pagnini, Edoardo Marrani, Chiara Azzari and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Immune response to viscerotropicFrontiers in immunology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Maria Vincenza MastroliaRheumatology Unit, Meyer Children's University Hospital, Viale Gaetano Pieraccini 24, Florence, 50139, Italy. maria.mastrolia@unifi.it.
Silvia BosciaImmunology and Molecular Microbiology Unit, Meyer Children's University Hospital, Florence, Italy.
Luisa GalliDepartment of Health Sciences, Pediatric Infectious Diseases Unit, University of Florence, Meyer Children's University Hospital, Florence, Italy.
Lorenzo LodiImmunology and Molecular Microbiology Unit, Department of Health Sciences, Meyer Children's University Hospital, University of Florence , Florence, Italy.
Laura PisanoImmunology and Molecular Microbiology Unit, Meyer Children's University Hospital, Florence, Italy.
Ilaria MaccoraRheumatology Unit, Meyer Children's University Hospital, Viale Gaetano Pieraccini 24, Florence, 50139, Italy.
Silvia RicciImmunology and Molecular Microbiology Unit, Department of Health Sciences, Meyer Children's University Hospital, University of Florence , Florence, Italy.
Ilaria PagniniRheumatology Unit, Meyer Children's University Hospital, Viale Gaetano Pieraccini 24, Florence, 50139, Italy.
Edoardo MarraniRheumatology Unit, Meyer Children's University Hospital, Viale Gaetano Pieraccini 24, Florence, 50139, Italy.
Chiara AzzariImmunology and Molecular Microbiology Unit, Department of Health Sciences, Meyer Children's University Hospital, University of Florence , Florence, Italy.
Gabriele SimoniniNEUROFARBA Department, Rheumatology Unit, Meyer Children's University Hospital, University of Florence, Florence, Italy.
Meyer Children's Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leishmaniasis is a cause of infection associated with hemophagocytic lymphohistiocytosis (HLH). The measurement of the CD8

conclusionWe report a case series of 4 Italian children suffering from HLH secondary to visceral Leishmaniasis in which the lymphocyte subset assay suggests a potential role of CD38 WHAT IS KNOWN: • Visceral Leishmaniasis is a well-known cause of infection associated with hemophagocytic lymphohistiocytosis (HLH). • The measurement of the CD8 WHAT IS NEW: • We report a case series of 4 Italian children suffering from HLH secondary to visceral Leishmaniasis in which the lymphocyte subset assay suggests a potential role of CD38

Indexed as

Leishmaniasis, VisceralLymphohistiocytosis, HemophagocyticBiomarkersCD8-Positive T-LymphocytesChildHLA-DR AntigensHumansBiomarkersHLA-DR AntigensCD38 cellsChildrenHemophagocytosisHLHLeishmania

Identifiers

PMID36631689
OpenAlexW4315607792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.